International Board of Directors

2023-2024 ISPE International Board of Directors

The Board is responsible for the governance and strategic direction of the Society. The following pharmaceutical industry leaders have been elected to positions on the 2023–2024 ISPE International Board of Directors:


Officers

Jeffrey A. Biskup, PE
Executive Chairman of the Board
CRB
Chair
Vivianne Arencibia
Vice President, Global Quality Systems and Compliance
Moderna
Vice Chair
Ylva Ek
Founder
Robur Life Science Advisory AB
Treasurer
Secretary
Scott W. Billman
Senior Vice President Global Engineering, Technology, & Facilities
Solventum
Immediate Past Chair
Michael Rutherford
Interim President and CEO
ISPE
Ex Officio Non-voting Member

Directors

David Churchward
Head of Operations Quality, Compliance and External Affairs
AstraZeneca
Liz Dooley
Senior Director, Global Engineering & Technology
Johnson & Johnson
Norman Goldschmidt
President
Genesis AEC
James Grunwald
Senior Vice President US Business Development
Arcadis
Shanshan Liu
Director
No Deviation Pte Ltd
Sarah Pope Miksinski
Executive Director, CMC Regulatory Affairs
Gilead Sciences, Inc.
Vivien Santillan
Regional Director, Asia
Novatek International
Georg Singewald
Global Head of Quality & Compliance
Roche / Genentech
Timothy J.N. Watson, PhD
Vice President – Head of CMC Regulatory Affairs
Gilead Sciences

Ex Officio

Rebecca Roscher
Project Manager
Bayer AG (Supply Center Grenzach)

2022 International Board of Directors Election Results

The ISPE International Board of Directors 2022 Election has concluded and the results are in. The leadership transition between the 2021 - 2022 Board and the 2022 - 2023 Board will take place during the 2022 ISPE Annual Meeting & Expo on Tuesday, 1 November.

Learn More


ISPE is governed by an elected board of directors. The board is composed of fifteen elected members and the CEO & President, who serves as a non-voting ex-officio member. Directors are elected to a two-year term and can serve up to two terms consecutively. All terms commence at Annual Meeting. The officer positions are Chair, Vice Chair, Treasurer, Secretary, Past Chair and the President as a non-voting ex officio member. Terms for officers are one year and the Secretary is the first officer position in the typical officer succession. Each candidate for secretary is typically making a five-year commitment to serve in the roles of Secretary through Past Chair. During the September 2016 meeting of the ISPE International Board of Directors, two important modifications were incorporated into the ISPE Bylaws. The Board approved the appointment of a Director level position to the Board and the current Chair of the International Emerging Leaders Committee will be invited to board meetings as an ex-officio (non-voting) member as well. The main objective of these appointments was to ensure that ISPE has the appropriate diversity within the Board to execute business strategies as defined in our ISPE Strategic Plan. For additional information on the actions from the last Board meeting or access to governance actions visit the Governance Documents FAQs page.